Evidence map›Paper›PMID 36307954›Full record

ArticleCellular signalling2016

Retraction notice to "REDOX regulation of IL-13 signaling in intestinal epithelial cells: usage of alternate pathways mediates distinct gene expression patterns" [Cell. Signal. 22/10 (October 2010) 1485-1494].

Debasmita Mandal, Pingfu Fu, Alan D Levine

Open access · greenAbstract readRetraction Notice
PubMed Full text at PMC Publisher
In one paragraph

Article in Cellular signalling, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 95% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Debasmita MandalDepartment of Pathology, 10900 Euclid Avenue, Case Western Reserve University School of Medicine, Cleveland, OH 44106-4952, United States.
Pingfu FuDepartment of Epidemiology and Biostatics, 10900 Euclid Avenue, Case Western Reserve University School of Medicine, Cleveland, OH 44106-4952, United States; Case Comprehensive Cancer Center, 10900 Euclid Avenue, Case Western Reserve University School of Medicine, Cleveland, OH 44106-4952, United States.
Alan D LevineDepartment of Pathology, 10900 Euclid Avenue, Case Western Reserve University School of Medicine, Cleveland, OH 44106-4952, United States; Department of Medicine, 10900 Euclid Avenue, Case Western Reserve University School of Medicine, Cleveland, OH 44106-4952, United States; Department of Pharmacology, 10900 Euclid Avenue, Case Western Reserve University School of Medicine, Cleveland, OH 44106-4952, United States; Case Comprehensive Cancer Center, 10900 Euclid Avenue, Case Western Reserve University School of Medicine, Cleveland, OH 44106-4952, United States. Electronic address: alan.levine@case.edu.
Case Western Reserve University · US

Funding

The Extracellular Matrix Inflammatory Bowel DiseaseR01DK054213 · NIDDK · CASE WESTERN RESERVE UNIVERSITY · PI LEVINE, ALAN DAVID · 1998 to 2010
$2.8M
Mucosal T Cells: Is Tolerance Floating on Lipid RaftsR01AI053188 · NIAID · CASE WESTERN RESERVE UNIVERSITY · PI LEVINE, ALAN DAVID · 2003 to 2007
$1.3M
NIAID NIH HHS R01 AI053188NIDDK NIH HHS R01 DK054213
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID36307954
PMCPMC9844235
OpenAlexW2469885854

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.